查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1919296

医用心臟环状成形术环市场（按环形状、产品类型、手术类型、材质类型、应用和最终用户划分）—2026-2032年全球预测

Medical Heart Annuloplasty Ring Market by Ring Shape, Product Type, Procedure Type, Material Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年，医用心臟环状成形术环市场价值为 4.4889 亿美元，预计到 2026 年将成长至 4.735 亿美元，年复合成长率为 4.28%，到 2032 年将达到 6.0218 亿美元。

关键市场统计数据
基准年 2025 4.4889亿美元
预计年份：2026年 4.735亿美元
预测年份 2032 6.0218亿美元
复合年增长率 (%) 4.28%

策略概述，介绍了影响环状成形术环环发展和应用的临床因素、器械设计演变以及医疗保健系统趋势。

本执行摘要概述了环状成形术环环的策略考量，重点在于临床创新、不断发展的器械设计和不断演变的治疗路径。它整合了当前的实践模式、器械差异化以及相关人员的奖励，为经营团队决策提供清晰的基础。分析优先考虑临床驱动因素，例如对保留瓣膜疗法的日益青睐、促进生物相容性的材料科学进步，以及旨在降低围手术全期风险和加速患者康復的微创手术方式的转变。

器械设计、手术流程创新和临床培训的进步正在汇聚，重新定义人们对环状成形术环的期望和应用路径。

环状成形术环市场格局正经历一场变革，其驱动力包括技术改进、手术创新以及临床医师偏好的转变。瓣环几何形状和材料科学的进步使得瓣环成形环的设计能够更精确地模拟天然瓣环的动态特性，从而提高修復的耐久性和功能效果。同时，手术创新正在加速微创手术的普及，而外科技术与辅助影像技术的结合，则使得瓣膜修復术的应用范围不断扩大，使其能够惠及那些传统上被认为不适合开胸手术的高风险患者群体。

了解关税变化引发的复杂供应链重组和采购行为：医疗设备采购和医院采购策略的转型

2025年实施的关税调整对医疗设备供应链产生了多方面的影响，波及到瓣环成形术成形环生态系统，影响了筹资策略、采购实务和商业规划。部分零件和成品进口关税的提高迫使製造商重新评估其全球采购结构，加速了邻近地区的生产扩张和供应商多元化，以降低贸易政策波动的风险。同时，医院和医疗系统对采购的审查力度加大，促使企业寻求签订长期合约和联合预测，以平抑成本波动并确保获得先进的修復技术。

基于深度细分的洞察，能够明确临床需求、设备设计权衡以及针对不同手术流程和最终用户环境的商业化路径。

细分市场层面的趋势揭示了微妙的临床和商业槓桿作用，这些槓桿作用指导着产品开发和市场定位。根据应用领域，二尖瓣修復和三尖瓣修復之间存在差异。二尖瓣手术可细分为退化性逆流和功能性逆流，而三尖瓣手术则分为原发性三尖瓣逆流和继发续发性三尖瓣逆流。每个临床亚类对瓣环的尺寸、贴合度和耐用性都有不同的要求。就瓣环形状而言，产品设计选择——柔软性、刚性和半刚性——体现了在维持生理运动和瓣环稳定性之间的权衡，这影响外科医生的偏好和患者的选择。

不同关键区域的临床重点、监管体系和采购行为如何推动客製化产品策略和推广路径

区域趋势将影响环状成形术环相关人员的采纳曲线和策略重点。每个地区都有其独特的临床实践、法律规范和医疗保健系统奖励。在美洲，临床重点通常在于儘早采用微创技术和强大的心臟外科网络，因此倾向于选择有助于患者更快康復和缩短住院时间的器械。同时，在欧洲、中东和非洲地区（EMEA），监管路径和采购机制存在差异，需要可调整的证据包和区域性商业模式，以适应不同的报销标准和医院采购习惯。

医疗器材製造商的竞争定位和策略部署正在影响外科医生的偏好、临床证据的优先顺序以及伙伴关係主导的成长策略。

环状成形术环领域的竞争动态主要由成熟製造商、专业器材公司和新兴创新者组成，每家公司都力求打造差异化的价值提案。成熟公司利用长期建立的临床关係、广泛的分销网络和丰富的临床数据，在手术量大的中心赢得青睐；而小规模的专业公司则往往透过新型材料、独特的几何形状或与微创输送系统的整合来寻求利基市场定位。新兴参与企业倾向于关注模组化和易于植入的特点，以此来推动外科医生采用，并强调缩短手术时间和与现代影像技术的兼容性。

器械製造商和医疗保健系统可采取的实际策略行动，以加速瓣膜修復疗法的应用、产生证据并增强供应链韧性

在瓣环成形术术器材领域寻求长期竞争优势的产业领导者，应采取一系列切实可行的策略，使产品创新与临床工作流程和支付方的期望相契合。优先投资于能够简化植入操作的设计，以支持微创和开放手术的广泛应用，同时保持瓣膜的生理运动。此外，还应建立强有力的临床证据项目，包括真实世界註册研究和性能比较研究，以展示长期疗效并为医保报销谈判提供依据。

我们采用严谨的多方法研究框架，整合临床医师访谈、监管审查和多资讯来源三角测量，以检验设备见解和策略意义。

本调查方法结合了定性和定量技术，以确保获得严谨透明的洞见，从而为策略决策提供基础。主要研究包括对心臟外科医生、采购主管和临床研究人员进行深度访谈，以收集关于器械性能、手术偏好和推广障碍的第一线观点。此外，还透过对外科技术文献和器械标籤的观察性审查，分析了设计特征与临床结果之间的关係。次要研究则涵盖了同行评审的临床研究、监管申报文件和技术白皮书，以检验器械特性和长期安全性。

该报告整合了临床、商业和价值链主题，提出了以设计主导的差异化、以证据为基础的采用和协作价值创造。

总之，环状成形术环的创新正朝着维持生理运动和手术实用性之间取得平衡的方向发展。不断发展的手术技术和对长期疗效日益重视为此提供了支持。器械的差异化越来越依赖材料科学、植入物几何形状以及与微创输送系统的兼容性，而实证医学证据的累积和培训计画则是市场接受度的关键。在贸易政策变化和采购审查日益严格的背景下，供应链韧性和本地化生产正从战术性考虑转变为战略要务。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按环类型分類的医用心臟环状成形术环市场

  • 灵活的
  • 刚性
  • 半刚性

9. 依产品类型分類的医用心臟环状成形术环市场

  • 完整环
  • 部分环

第十章 依手术类型分類的医用心臟环状成形术环市场

  • 微创手术
    • 机器人辅助
    • 胸腔镜手术
  • 开胸手术

第十一章 依材料类型分類的医用心臟环状成形术环市场

  • 聚酯纤维
  • PTFE

第十二章 按应用分類的医用心臟环状成形术环市场

  • 二尖瓣修復
    • 退化性逆流
    • 功能性逆流
  • 三尖瓣修復
    • 原发性三尖瓣逆流
    • 继发性次发性逆流

第十三章 依最终使用者分類的医用心臟环状成形术环市场

  • 门诊手术中心
  • 心臟外科中心
  • 医院

第十四章 区域性心臟环状成形术环市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 医疗心臟环状成形术环市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国医用心臟环状成形术环市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国医用心臟环状成形术环市场

第十八章：中国医用心臟环状成形术环市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • AtriCure, Inc.
  • B. Braun Melsungen AG
  • Balton SA
  • BioStable Science & Engineering LLC
  • BioVentrix, Inc.
  • Cardiac Science Corporation
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Geister Medizintechnik GmbH
  • HeartWare International, Inc.
  • Jotec GmbH
  • Kardia Medical, Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LifeLine Cardiology, Inc.
  • LivaNova plc
  • Medistim ASA
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Peijia Medical Technology Co., Ltd.
  • Shenzhen Weigao Group Medical Polymer Company Limited
  • St. Jude Medical, Inc.
  • Terumo Corporation
Product Code: MRR-F14BA1B34199

The Medical Heart Annuloplasty Ring Market was valued at USD 448.89 million in 2025 and is projected to grow to USD 473.50 million in 2026, with a CAGR of 4.28%, reaching USD 602.18 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 448.89 million
Estimated Year [2026] USD 473.50 million
Forecast Year [2032] USD 602.18 million
CAGR (%) 4.28%

A strategic primer presenting clinical drivers, device design evolution, and healthcare system dynamics shaping annuloplasty ring development and adoption

This executive summary distills the strategic considerations surrounding heart annuloplasty rings, emphasizing clinical innovation, device design evolution, and evolving care pathways. It synthesizes current practice patterns, device differentiation, and stakeholder incentives to provide a clear foundation for executive decision-making. The analysis prioritizes clinical drivers such as the increasing preference for valve-preserving therapies, material science advances fostering biocompatibility, and procedural shifts toward less invasive approaches that aim to reduce perioperative risk and accelerate patient recovery.

In addition, the summary highlights how regulatory scrutiny and reimbursement frameworks shape product development priorities, influencing design choices and clinical evidence generation. It also outlines the competitive dynamics that arise from new entrants and incremental innovation, clarifying how established manufacturers and innovative device companies position their portfolios across clinical subsegments. Ultimately, the introduction sets the stage for deeper insights by framing the interplay between clinical need, engineering solutions, and health system adoption, enabling stakeholders to align product, clinical trials, and commercialization strategies with emerging provider expectations and patient outcomes.

How advancements in device design, procedural innovation, and clinical training are collectively redefining expectations and adoption pathways for annuloplasty rings

The landscape for annuloplasty rings has experienced transformative shifts driven by technological refinement, procedural innovation, and changing clinician preferences. Advances in ring geometry and material science have enabled designs that better mimic native annular dynamics, thereby improving repair durability and functional outcomes. Simultaneously, procedural innovation has accelerated the movement toward minimally invasive access, where surgical techniques and adjunctive imaging converge to expand the candidacy for valve repair in patients once deemed high risk for open procedures.

Moreover, talent diffusion across cardiac surgery teams and investment in surgeon training programs have reduced variability in procedural outcomes, which in turn has emboldened clinical adoption of newer ring designs. On the regulatory front, governing bodies have encouraged robust post-market surveillance and real-world evidence generation, nudging manufacturers to invest in longitudinal follow-up and registries. These combined shifts have reshaped value propositions: where once durability and basic hemodynamics dominated, contemporary differentiation now rests on ease of implantation, physiologic motion preservation, and compatibility with minimally invasive platforms. Consequently, companies and providers that anticipate these combined forces and invest in integrated solutions stand to influence standard-of-care trajectories.

Understanding the complex supply chain realignment and procurement behaviors triggered by tariff changes that reshaped device sourcing and hospital purchasing strategies

The advent of tariff adjustments affecting medical device supply chains in 2025 introduced multifaceted implications for the annuloplasty ring ecosystem, influencing sourcing strategies, procurement practices, and commercial planning. Higher import duties on certain components and finished devices prompted manufacturers to re-evaluate global sourcing footprints, accelerating near-shore production and supplier diversification to mitigate exposure to trade policy fluctuations. At the same time, increased procurement scrutiny by hospitals and health systems encouraged longer-term contracting and collaborative forecasting to smooth cost volatility and preserve access to advanced repair technologies.

Clinically, providers seeking to manage device spend without compromising patient care began emphasizing product selection frameworks that balance device performance with total procedural cost. Payers and hospital procurement teams intensified evaluations of cost-effectiveness and supply chain resilience, which in turn affected formulary placement and purchasing agreements. For device innovators, tariff-driven cost pressures underscored the strategic value of modular product architectures and local manufacturing partnerships that can bypass tariff layers while maintaining quality controls. In summary, the cumulative tariff impact catalyzed supply chain realignment, reshaped procurement behaviors, and elevated strategic conversations about manufacturing localization and lifecycle cost management.

Deep segmentation-driven insights that clarify clinical requirements, device design trade-offs, and targeted commercialization pathways across diverse procedural and end-user contexts

Segment-level dynamics reveal nuanced clinical and commercial levers that guide product development and market positioning. Based on application, differentiation emerges across mitral valve repair and tricuspid valve repair, where mitral interventions subdivide into degenerative regurgitation and functional regurgitation, and tricuspid interventions divide into primary tricuspid regurgitation and secondary tricuspid regurgitation; each of these clinical subcategories imposes distinct demands on ring sizing, conformability, and durability. In terms of ring shape, product design choices among flexible, rigid, and semi-rigid options reflect trade-offs between physiologic motion preservation and annular stabilization, affecting surgeon preference and patient selection.

Product type segmentation between complete ring and partial ring drives implantation strategies and intraoperative workflow, while procedure type distinctions between minimally invasive procedures and open heart procedures-where minimally invasive approaches further include robotic assisted and thoracoscopic techniques-shape device delivery systems, training requirements, and instrumentation ecosystems. End user segmentation across ambulatory surgical centers, cardiac surgery centers, and hospitals influences procurement cycles, case mix, and capital equipment planning. Finally, material type considerations such as polyester versus PTFE underpin long-term biocompatibility, suture handling, and tissue integration profiles, guiding both regulatory strategy and clinical messaging. Together, these segments inform targeted clinical evidence generation, differentiated go-to-market strategies, and prioritized R&D investments.

How distinct clinical priorities, regulatory systems, and procurement behaviors across major global regions drive tailored product strategies and adoption pathways

Regional dynamics shape adoption curves and strategic priorities for annuloplasty ring stakeholders, with each geography presenting distinct clinical practices, regulatory frameworks, and health system incentives. In the Americas, clinical emphasis often centers on early adoption of minimally invasive techniques and robust cardiac surgery networks, which favor devices that support rapid recovery and reduced length of stay. Conversely, Europe, Middle East & Africa exhibits heterogeneity in regulatory pathways and procurement mechanisms, requiring adaptable evidence packages and region-specific commercial models to address varying reimbursement norms and hospital purchasing practices.

Asia-Pacific markets combine rapidly expanding procedural volumes with an increasing emphasis on domestic manufacturing and regional clinical training programs, which encourages manufacturers to tailor product offerings and service models for scale and affordability. Across all regions, collaborative partnerships with local clinical leaders and investment in training programs have proven effective in accelerating uptake. Transitioning from regional observations to actionable strategy, manufacturers should calibrate regulatory submissions, build localized evidence generation, and structure commercial operations to reflect each region's distinct mix of clinical need, purchasing behavior, and health system complexity.

Competitive positioning and strategic maneuvers by device makers shaping surgeon preference, clinical evidence priorities, and partnership-driven growth strategies

Competitive dynamics in the annuloplasty ring arena center on a mixture of legacy manufacturers, specialized device firms, and emerging innovators, each pursuing differentiated value propositions. Established companies leverage long-standing clinical relationships, extensive distribution networks, and a breadth of clinical data to secure preference in high-volume centers, while smaller specialists often seek niche positioning through novel materials, proprietary geometries, or integration with minimally invasive delivery systems. Emerging entrants tend to focus on modularity and ease of implantation as a route to surgeon adoption, emphasizing reduced procedural time and compatibility with contemporary imaging modalities.

Strategic partnerships and targeted acquisitions have become common tactics to fill portfolio gaps, accelerate entry into minimally invasive markets, and extend service offerings. Additionally, firms investing in longitudinal real-world evidence and registries strengthen clinical credibility and payer conversations. For purchasing institutions, the vendor selection process increasingly evaluates not only product performance but also training support, supply chain resilience, and lifecycle cost transparency. Collectively, these factors are shaping competitive positioning and informing where companies choose to invest in clinical research, manufacturing capabilities, and commercial enablement.

Practical strategic actions for device manufacturers and health systems to enhance adoption, evidence generation, and supply chain resilience in valve repair therapies

Industry leaders aiming to secure long-term relevance in annuloplasty devices should pursue a set of actionable strategies that align product innovation with clinical workflows and payer expectations. Prioritize investment in designs that preserve physiologic annular motion while simplifying implantation to support wider adoption across both minimally invasive and open approaches. Concurrently, build robust clinical evidence programs that include real-world registries and comparative performance studies to demonstrate long-term outcomes and inform reimbursement discussions.

Operationally, strengthen supplier diversity and consider regional manufacturing partnerships to hedge against trade-related disruptions and to meet local procurement preferences. Complement these moves with surgeon-focused training initiatives and proctorship programs that reduce the learning curve for new techniques and devices. Finally, develop comprehensive value communication packages that translate clinical benefits into economic terms meaningful to hospital administrators and payers, emphasizing reduced complications, shorter stays, and procedural efficiency. Executed together, these actions will help manufacturers and health systems align on sustainable adoption pathways and deliver measurable improvements in patient care.

A rigorous multi-method research framework that integrates clinician interviews, regulatory review, and cross-source triangulation to validate device insights and strategic implications

The research methodology combines qualitative and quantitative techniques to ensure rigorous, transparent findings that inform strategic decision-making. Primary research included in-depth interviews with cardiac surgeons, procurement leaders, and clinical researchers to capture first-hand perspectives on device performance, procedural preferences, and adoption barriers. These conversations were supplemented by observational review of surgical technique literature and device labeling to map design features to clinical outcomes. Secondary research encompassed peer-reviewed clinical studies, regulatory filings, and technical white papers to validate device attributes and long-term safety profiles.

Data synthesis employed triangulation across sources to reconcile differing viewpoints and to identify persistent themes. Where appropriate, sensitivity analyses were used to explore how changes in clinical practice or procurement policies could alter adoption dynamics. Quality assurance procedures included cross-validation of interview findings against clinical publications and consultation with independent clinical experts to ensure interpretation fidelity. This layered approach provides a robust foundation for the conclusions and recommendations presented in the report, while maintaining transparency about data sources and analytical assumptions.

Synthesis of clinical, commercial, and supply chain themes pointing to design-led differentiation, evidence-driven adoption, and collaborative value articulation

In conclusion, annuloplasty ring innovation is converging toward solutions that balance physiologic motion preservation with surgical practicality, supported by evolving procedural techniques and heightened attention to long-term outcomes. Device differentiation will increasingly depend on a combination of material science, implant geometry, and compatibility with minimally invasive delivery systems, while evidence generation and training programs will be pivotal for market acceptance. Supply chain resilience and localized manufacturing have moved from tactical considerations to strategic imperatives in light of shifting trade policies and procurement scrutiny.

Looking ahead, manufacturers that integrate clinical evidence strategies with surgeon-centric design and robust commercial support will be best positioned to influence clinical practice and secure durable adoption. Health systems and payers will continue to demand transparent value narratives that align patient outcomes with economic realities, encouraging collaborations that link device innovation with measurable improvements in care pathways. Taken together, these themes underscore a pathway for stakeholders to translate technical advancements into better patient outcomes and sustainable commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Heart Annuloplasty Ring Market, by Ring Shape

  • 8.1. Flexible
  • 8.2. Rigid
  • 8.3. Semi-Rigid

9. Medical Heart Annuloplasty Ring Market, by Product Type

  • 9.1. Complete Ring
  • 9.2. Partial Ring

10. Medical Heart Annuloplasty Ring Market, by Procedure Type

  • 10.1. Minimally Invasive Procedure
    • 10.1.1. Robotic Assisted
    • 10.1.2. Thoracoscopic
  • 10.2. Open Heart Procedure

11. Medical Heart Annuloplasty Ring Market, by Material Type

  • 11.1. Polyester
  • 11.2. PTFE

12. Medical Heart Annuloplasty Ring Market, by Application

  • 12.1. Mitral Valve Repair
    • 12.1.1. Degenerative Regurgitation
    • 12.1.2. Functional Regurgitation
  • 12.2. Tricuspid Valve Repair
    • 12.2.1. Primary Tricuspid Regurgitation
    • 12.2.2. Secondary Tricuspid Regurgitation

13. Medical Heart Annuloplasty Ring Market, by End User

  • 13.1. Ambulatory Surgical Center
  • 13.2. Cardiac Surgery Center
  • 13.3. Hospital

14. Medical Heart Annuloplasty Ring Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Medical Heart Annuloplasty Ring Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Medical Heart Annuloplasty Ring Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Medical Heart Annuloplasty Ring Market

18. China Medical Heart Annuloplasty Ring Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. AtriCure, Inc.
  • 19.7. B. Braun Melsungen AG
  • 19.8. Balton S.A.
  • 19.9. BioStable Science & Engineering LLC
  • 19.10. BioVentrix, Inc.
  • 19.11. Cardiac Science Corporation
  • 19.12. CryoLife, Inc.
  • 19.13. Edwards Lifesciences Corporation
  • 19.14. Geister Medizintechnik GmbH
  • 19.15. HeartWare International, Inc.
  • 19.16. Jotec GmbH
  • 19.17. Kardia Medical, Inc.
  • 19.18. Lepu Medical Technology (Beijing) Co., Ltd.
  • 19.19. LifeLine Cardiology, Inc.
  • 19.20. LivaNova plc
  • 19.21. Medistim ASA
  • 19.22. Medtronic plc
  • 19.23. MicroPort Scientific Corporation
  • 19.24. Peijia Medical Technology Co., Ltd.
  • 19.25. Shenzhen Weigao Group Medical Polymer Company Limited
  • 19.26. St. Jude Medical, Inc.
  • 19.27. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SEMI-RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SEMI-RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SEMI-RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COMPLETE RING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COMPLETE RING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COMPLETE RING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PARTIAL RING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PARTIAL RING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PARTIAL RING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY THORACOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY THORACOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY THORACOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY OPEN HEART PROCEDURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY OPEN HEART PROCEDURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY OPEN HEART PROCEDURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY DEGENERATIVE REGURGITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY DEGENERATIVE REGURGITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY DEGENERATIVE REGURGITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY FUNCTIONAL REGURGITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY FUNCTIONAL REGURGITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY FUNCTIONAL REGURGITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRIMARY TRICUSPID REGURGITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRIMARY TRICUSPID REGURGITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRIMARY TRICUSPID REGURGITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SECONDARY TRICUSPID REGURGITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SECONDARY TRICUSPID REGURGITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SECONDARY TRICUSPID REGURGITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY CARDIAC SURGERY CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY CARDIAC SURGERY CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY CARDIAC SURGERY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 171. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 172. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 198. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 201. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 202. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 205. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 208. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 211. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 212. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)